Increased osteoblastic activity and decreased osteoclastogenesis in TgLRAP cells <i>in vitro</i>. by Naoto Haruyama (487384)

“…No differences were found between WT and TgLRAP. Bars = 1 mm. <b>D,</b> TRAP staining of co-cultured BMCs and calvarial cells at 7 days of osteoclast induction. …”

Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

“…(<b>D,E</b>) The channel open probability was evaluated by measuring the degree of MTSEA (200 μM) potentiation using TEVC recordings from <i>Xenopus</i> oocytes expressing the WT GluN2A (<i>left panel</i>) or the mutant GluN2A(D731N) (<i>right panel</i>) coexpressed with GluN1(A652C) at a holding potential of -40 mV in presence of EC₅₀ concentrations of glutamate with saturating concentration (100 μM) of glycine (open bar) and 0.2 mM MTSEA (closed bar). …”

Expression of MHC I is decreased by P2X7R activation. by Alberto Baroja-Mazo (441935)

Inhibition of PKC decreases colony formation of carcinoma cells. by Nataliya Kotelevets (156133)

Intracellular levels of HSPG core proteins, HS and HPSE are decreased in ER stressed MIN6 cells. by Sarita Dhounchak (10924448)

Decreased primary seed dormancy and vivipary phenotype of <i>abi4</i>. by Kai Shu (424728)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”

TcMTH and EcMutT parasites effectively decreased DHR oxidation and show increase in antioxidant enzyme expression. by Grazielle R. Goes (2585713)

WT∶MU ratio is decreased in differentiated hOE-MSCs. by Nathalie Boone (234904)

Silencing of Rap1A decreases ERK and p38 activation. by Yougen Wu (830191)

Inhibition of Hsp90 abolished VEGF-mediated eNOS phosphorylation and decreased NO production and cell viability in BAECs. by Yuanzhuo Chen (802891)

CCR2 depletion decreases lipid accumulation in the liver and WAT. by Seung Joo Lee (1766020)

“…Increased lipid droplets and fat size in HFD WT were decreased in HFD KO. Arrow indicates a crown-like structure. …”

Absence of p62 leads to decreased acetylated-tubulin in mouse fibroblasts. by Jin Yan (193119)

Predictive values of IC₅₀ in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC₅₀ in mM (FFAs) and decreasing blood glucose level. by Elena V. Fedorova (603922)

“…<p>Predictive values of IC₅₀ in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC₅₀ in mM (FFAs) and decreasing blood glucose level.…”

WT1 mRNA and protein levels are decreased by GnRH. by Debalina Bagchi (686046)

Probability of release is decreased by hydrophobic mutations. by Matthew R. Bowers (8423115)

Inhibition of GATA2 in clinical primary AML cells decreased the survival rate during chemo treatment. by Li Yang (6520)

Knockout or inhibition of CCR1 decreases peritoneal inflammation and CAIA. by Nuruddeen D. Lewis (192385)

Pretreatment with SDG prevents iron induced decrease in H9c2 cell size. by Stephanie Puukila (568109)